These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9585891)

  • 1. Delivering hydrosoluble compounds through the skin: what are the chances?
    Demartis S; Rassu G; Mazzarello V; Larrañeta E; Hutton A; Donnelly RF; Dalpiaz A; Roldo M; Guillot AJ; Melero A; Giunchedi P; Gavini E
    Int J Pharm; 2023 Nov; 646():123457. PubMed ID: 37788729
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation, characterization, dissolution, and permeation of flibanserin - 2-HP-β-cyclodextrin inclusion complexes.
    Alghaith AF; Mahrous GM; Zidan DE; Alhakamy NA; Alamoudi AJ; Radwan AA
    Saudi Pharm J; 2021 Sep; 29(9):963-975. PubMed ID: 34588842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins in delivery systems: Applications.
    Tiwari G; Tiwari R; Rai AK
    J Pharm Bioallied Sci; 2010 Apr; 2(2):72-9. PubMed ID: 21814436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrins in drug delivery: an updated review.
    Challa R; Ahuja A; Ali J; Khar RK
    AAPS PharmSciTech; 2005 Oct; 6(2):E329-57. PubMed ID: 16353992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous absorption of topically applied medication.
    Rudy SJ; Parham-Vetter PC
    Dermatol Nurs; 2003 Apr; 15(2):145-6, 150-2. PubMed ID: 12751350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles and approaches for optimizing therapy with unique topical vehicles.
    Rosen J; Landriscina A; Friedman AJ
    J Drugs Dermatol; 2014 Dec; 13(12):1431-5. PubMed ID: 25607783
    [No Abstract]   [Full Text] [Related]  

  • 7. Systems that enhance skin drug delivery.
    Bauer EA; Cohen DE
    Dermatol Ther; 2011; 24(5):463. PubMed ID: 22353151
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclodextrins: new drug delivery systems in dermatology.
    Loftsson T; Olafsson JH
    Int J Dermatol; 1998 Apr; 37(4):241-6. PubMed ID: 9585891
    [No Abstract]   [Full Text] [Related]  

  • 9. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
    Hu J; Tao Z; Cao S
    Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation design for topical drug and nanoparticle treatment of skin disease.
    Raphael AP; Garrastazu G; Sonvico F; Prow TW
    Ther Deliv; 2015 Feb; 6(2):197-216. PubMed ID: 25690087
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.